Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study

American Journal of Kidney Diseases

Volumn 53, Issue 4, 2009, Pages 596-605

  Bash, Lori D ^a,b   Erlinger, Thomas P ^c   Coresh, Josef ^a,b,d   Marsh Manzi, Jane ^b   Folsom, Aaron R ^e   Astor, Brad C ^a,b,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Seton Hospital   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Atherosclerosis Risk in Communities (ARIC); chronic kidney disease; hemostasis; Inflammation; kidney

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CREATININE; FIBRINOGEN; SERUM ALBUMIN; VON WILLEBRAND FACTOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEMOSTASIS; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATION; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RACE; RISK FACTOR; SEX; SMOKING; STATISTICAL ANALYSIS;

BIOLOGICAL MARKERS; CHRONIC DISEASE; COHORT STUDIES; CREATININE; DISEASE PROGRESSION; FACTOR VIII; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOSTASIS; HUMANS; INFLAMMATION; KIDNEY DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; UNITED STATES; VON WILLEBRAND FACTOR;

EID: 62749159031     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.10.044     Document Type: Article

References (34)

1. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health And Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
2. Collins A.J., Kasiske B., Herzog C., et al., US Renal Data System Excerpts from the United States Renal Data System. 2004 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 45 (2005) A5-A7
3. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
4. Klag M.J., Whelton P.K., Randall B.L., et al. Blood pressure and end-stage renal disease in men. N Engl J Med 334 (1996) 13-18
5. Erlinger T.P., Tarver-Carr M.E., Powe N.R., et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis 42 (2003) 256-263
6. Fried L., Solomon C., Shlipak M., et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol 15 (2004) 3184-3191
7. Kshirsagar A.V., Bomback A.S., Bang H., et al. Association of C-reactive protein and microalbuminuria (from the National Health And Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol 101 (2008) 401-406
8. Bleyer A.J., Shemanski L.R., Burke G.L., Hansen K.J., and Appel R.G. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57 (2000) 2072-2079
9. Orchard T.J., Chang Y.F., Ferrell R.E., Petro N., and Ellis D.E. Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities?. Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62 (2002) 963-970
10. Sarnak M.J., Poindexter A., Wang S.R., et al. Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62 (2002) 2208-2215
11. ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) Study: Design and objectives. Am J Epidemiol 129 (1989) 687-702
12. Shoham D.A., Vupputuri S., Diez Roux A.V., et al. Kidney disease in life-course socioeconomic context: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 49 (2007) 217-226
13. National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study: Operations manual no. 10: clinical chemistry determinations. Version 1.0 (1987), ARIC Coordinating Center, School of Public Health, University of North Carolina, Chapel Hill, NC
14. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
15. Eckfeldt J.H., Chambless L.E., and Shen Y.L. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk In Communities study. Arch Pathol Lab Med 118 (1994) 496-500
16. Papp A.C., Hatzakis H., Bracey A., and Wu K.K. ARIC hemostasis study-I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 61 (1989) 15-19
17. National Heart, Lung, and Blood Institute, Atherosclerosis Risk in Communities (ARIC) Study: Operation manual no. 9: hemostasis determinations. Version 1.0 (1987), ARIC Coordinating Center, School of Public Health, University of North Carolina, Chapel Hill, NC
18. Folsom A.R., Rosamond W.D., Shahar E., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100 (1999) 736-742
19. Chambless L.E., McMahon R., Wu K., Folsom A., Finch A., and Shen Y.L. Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities intraindividual variability study. Ann Epidemiol 2 (1992) 723-733
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Carroll R., and Stefanski L. Approximate quasilikelihood estimation in models with surrogate predictors. J Am Stat Assoc 85 (1990) 652-663
22. Gleser L.J. Improvements of the naïve approach to estimation in nonlinear errors-in-variables regression models. In: Brown P.J., and Fuller W.A. (Eds). Statistical Analysis of Measurement Error Models and Applications (1990), American Mathematical Society, Providence, RI 99-114
23. Hardin J., Schmiediche H., and Carroll R. The regression calibration method for fitting generalized linear models with additive measurement error. Stata J 3 (2003) 361-372
24. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
25. Singh D., Whooley M.A., Ix J.H., Ali S., and Shlipak M.G. Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study. Nephrol Dial Transplant 22 (2007) 1087-1092
26. Huebschmann A.G., Regensteiner J.G., Vlassara H., and Reusch J.E. Diabetes and advanced glycoxidation end products. Diabetes Care 29 (2006) 1420-1432
27. Cooper M.E. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 17 12 pt 2 (2004) 31S-38S
28. Forbes J.M., Thallas-Bonke V., Cooper M.E., and Thomas M.C. Advanced glycation: How are we progressing to combat this web of sugar anomalies in diabetic nephropathy. Curr Pharm Des 10 (2004) 3361-3372
29. Forbes J.M., Fukami K., and Cooper M.E. Diabetic nephropathy: Where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 115 (2007) 69-84
30. Pou K.M., Massaro J.M., Hoffmann U., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 116 (2007) 1234-1241
31. Sika M., Lewis J., Douglas J., et al., AASK Group. Baseline characteristics of participants in the African American Study of Kidney disease and Hypertension (AASK) clinical trial and cohort study. Am J Kidney Dis 50 (2007) 78-89 89.e1
32. Stehouwer C.D., Nauta J.J., Zeldenrust G.C., Hackeng W.H., Donker A.J., and den Ottolander G.J. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340 (1992) 319-323
33. Nadar S.K., Blann A.D., Kamath S., Beevers D.G., and Lip G.Y. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian cardiac outcomes trial (ASCOT). J Am Coll Cardiol 44 (2004) 415-422
34. Catena C., Zingaro L., Casaccio D., and Sechi L.A. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109 (2000) 556-561